Compartmentalization of proteolysis

Proteases: Structure and Function

Volumn , Issue , 2013, Pages 85-125

  Brix, Klaudia ^a   Scott, Christopher J ^b   Heck, Margarete M S ^c  

^a JACOBS UNIVERSITY BREMEN   (Germany)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926498940     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-0885-7_3     Document Type: Chapter

References (455)

1. Abele R, Tampe R (2006) Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett 580(4):1156-1163
2. Abele R, Tampe R (2009) Peptide trafficking and translocation across membranes in cellular signaling and self-defense strategies. Curr Opin Cell Biol 21(4):508-515
3. Abrahamson M, Alvarez-Fernandez M, Nathanson CM (2003) Cystatins. Biochem Soc Symp 70:179-199
4. Adhikari A, Xu M, Chen ZJ (2007) Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26(22):3214-3226
5. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87(2):171
6. Andrews NW (2000) Regulated secretion of conventional lysosomes. Trends Cell Biol 10 (8):316-321
7. Annaert W, De Strooper B (1999) Presenilins: molecular switches between proteolysis and signal transduction. Trends Neurosci 22(10):439-443
8. Apte SS (2004) A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 36(6):981-985
9. Arampatzidou M, Mayer K, Iolyeva ME, Gebre Asrat S, Ravichandran M, Gunther R, Schule T, Reinheckel T, Brix K (2011) Studies of intestinal morphology and cathepsin B expressing in a transgenic mouse aiming at intestine-specific expression of CathB-EGFP. Biol Chem 392:983-993
10. Arampatzidou M, Rehders M, Dauth S, Yu DMT, Tedelind S, Brix K (2011) Imaging of protease functions-current guide to spotting cysteine cathepsins in classical and novel scenes of action in mammalian epithelial cells and tissues. Ital J Anat Embryol 116(1):1-19
11. Arampatzidou M, Schutte A, Hansson GC, Saftig P, Brix K (2012) Effects of cathepsin K deficiency on intercellular junction proteins, luminal mucus layers, and extracellular matrix constituents in the mouse colon. Biol Chem 393:1391-1403
12. Arias E, Cuervo AM (2011) Chaperone-mediated autophagy in protein quality control. Curr Opin Cell Biol 23(2):184-189
13. Arolas JL, Vendrell J, Aviles FX, Fricker LD (2007) Metallocarboxypeptidases: emerging drug targets in biomedicine. Curr Pharm Des 13(4):349-366
14. Authier F, Posner BI, Bergeron JJ (1996) Insulin-degrading enzyme. Clin Invest Med 19 (3):149-160
15. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ (2006) Biological functions of maspin. J Cell Physiol 209(3):617-624
16. Bank U, Bohr UR, Reinhold D, Lendeckel U, Ansorge S, Malfertheiner P, Tager M (2008) Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl-And alanylaminopeptidase inhibitors. Front Biosci 13:3699-3713
17. Barrett AJ (1979) Cathepsin D: the lysosomal aspartic proteinase. Ciba Found Symp 75:37-50
18. Barrett AJ (2004) Bioinformatics of proteases in the MEROPS database. Curr Opin Drug Discov Devel 7(3):334-341
19. Barrett AJ, Kirschke H (1981) Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol 80 (Pt C):535-561
20. Barrett AJ, Rawlings ND (2001) Evolutionary lines of cysteine peptidases. Biol Chem 382 (5):727-733
21. Barrett AJ, Rawlings ND (2007) 'Species' of peptidases. Biol Chem 388(11):1151-1157
22. Barrett AJ, Rawlings ND, O'Brien EA (2001) The MEROPS database as a protease information system. J Struct Biol 134(2-3):95-102
23. Barrett AJ, Tolle DP, Rawlings ND (2003) Managing peptidases in the genomic era. Biol Chem 384(6):873-882
24. Baruch A, Jeffery DA, Bogyo M(2004) Enzyme activity-it's all about image. Trends Cell Biol 14 (1):29-35
25. Basbaum CB, Werb Z (1996) Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 8(5):731-738
26. Behrendt N (2004) The urokinase receptor (uPAR) and the uPAR-Associated protein (uPARAP/ Endo180): membrane proteins engaged in matrix turnover during tissue remodeling. Biol Chem 385(2):103-136
27. Bergers G, Coussens LM (2000) Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev 10(1):120-127
28. Bhat KP, Greer SF (2011) Proteolytic and non-proteolytic roles of ubiquitin and the ubiquitin proteasome system in transcriptional regulation. Biochim Biophys Acta 1809(2):150-155
29. Blasi F (1993) Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15(2):105-111
30. Blasi F, Carmeliet P (2002) uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3 (12):932-943
31. Blobel CP (2000) Remarkable roles of proteolysis on and beyond the cell surface. Curr Opin Cell Biol 12(5):606-612
32. Blobel CP (2000) Functional processing of fertilin: evidence for a critical role of proteolysis in sperm maturation and activation. Rev Reprod 5(2):75-83
33. Blum G (2008) Use of fluorescent imaging to investigate pathological protease activity. Curr Opin Drug Discov Devel 11(5):708-716
34. Blum G, Mullins SR, Keren K, Fonovic M, Jedeszko C, Rice MJ, Sloane BF, Bogyo M (2005) Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol 1(4):203-209
35. Bode W, Huber R (1992) Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem 204(2):433-451
36. Bode W, Huber R (2000) Structural basis of the endoproteinase-protein inhibitor interaction. Biochim Biophys Acta 1477(1-2):241-252
37. Bode W, Maskos K (2001) Structural studies on MMPs and TIMPs. Methods Mol Biol 151:45-77
38. Bode W, Maskos K (2003) Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Biol Chem 384(6):863-872
39. Bode W, Renatus M (1997) Tissue-Type plasminogen activator: variants and crystal/solution structures demarcate structural determinants of function. Curr Opin Struct Biol 7(6):865-872
40. Bode W, Grams F, Reinemer P, Gomis-Ruth FX, Baumann U, McKay DB, Stocker W(1996) The metzincin-superfamily of zinc-peptidases. Adv Exp Med Biol 389:1-11
41. Bode W, Brandstetter H, Mather T, Stubbs MT (1997) Comparative analysis of haemostatic proteinases: structural aspects of thrombin, factor Xa, factor IXa and protein C. Thromb Haemost 78(1):501-511
42. Bode W, Fernandez-Catalan C, Nagase H, Maskos K (1999) Endoproteinase-protein inhibitor interactions. APMIS 107(1):3-10
43. Bonifacino JS, Weissman AM (1998) Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu Rev Cell Dev Biol 14:19-57
44. Brandstetter H, Kim JS, Groll M, Huber R (2001) Crystal structure of the tricorn protease reveals a protein disassembly line. Nature 414(6862):466-470
45. Bresciani R, Von Figura K (1996) Dephosphorylation of the mannose-6-phosphate recognition marker is localized in later compartments of the endocytic route. Identification of purple acid phosphatase (uteroferrin) as the candidate phosphatase. Eur J Biochem 238(3):669-674
46. Brew K, Nagase H (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803(1):55-71
47. Brinckerhoff CE, Matrisian LM (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3(3):207-214
48. Brix K (2005) Lysosomal proteases: revival of the sleeping beauty, Chap. 5. In: Saftig P (ed) Lysosomes. Landes Bioscience/Eurekah.com/Springer, Georgetown, TX
49. Brix K, Herzog V (1994) Extrathyroidal release of thyroid hormones from thyroglobulin by J774 mouse macrophages. J Clin Invest 93(4):1388-1396
50. Brix K, Jordans S (2005) Watching proteases in action. Nat Chem Biol 1(4):186-187
51. Brix K, Lemansky P, Herzog V (1996) Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. Endocrinology 137(5):1963-1974
52. Brix K, Wirtz R, Herzog V (1997) Paracrine interaction between hepatocytes and macrophages after extrathyroidal proteolysis of thyroglobulin. Hepatology 26(5):1232-1240
53. Brix K, Linke M, Tepel C, Herzog V (2001) Cysteine proteinases mediate extracellular prohormone processing in the thyroid. Biol Chem 382(5):717-725
54. Brix K, Dunkhorst A, Mayer K, Jordans S (2008) Cysteine cathepsins: cellular roadmap to different functions. Biochimie 90(2):194-207
55. Brix K, Fuhrer D, Biebermann H (2011) Molecules important for thyroid hormone synthesis and action-known facts and future perspectives. Thyroid Res 4(Suppl 1):S9
56. Bromme D, Okamoto K (1995) Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe Seyler 376(6):379-384
57. Brooks P, Fuertes G, Murray RZ, Bose S, Knecht E, Rechsteiner MC, Hendil KB, Tanaka K, Dyson J, Rivett J (2000) Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem J 346(Pt 1):155-161
58. Brooks P, Murray RZ, Mason GG, Hendil KB, Rivett AJ (2000) Association of immunoproteasomes with the endoplasmic reticulum. Biochem J 352(Pt 3):611-615
59. Brown MS, Ye J, Rawson RB, Goldstein JL (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100(4):391-398
60. Brunner G, Preissner KT (1994) Pericellular enzymatic hydrolysis: implications for the regulation of cell proliferation in the vessel wall and the bone marrow. Blood Coagul Fibrinolysis 5 (4):625-639
61. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15:269-290
62. Bugge TH, List K, Szabo R (2007) Matriptase-dependent cell surface proteolysis in epithelial development and pathogenesis. Front Biosci 12:5060-5070
63. Burden RE, Snoddy P, Jefferies CA, Walker B, Scott CJ (2007) Inhibition of cathepsin L-like proteases by cathepsin V propeptide. Biol Chem 388(5):541-545
64. Buth H, Wolters B, Hartwig B, Meier-Bornheim R, Veith H, Hansen M, Sommerhoff CP, Schaschke N, Machleidt W, Fusenig NE, Boukamp P, Brix K (2004) HaCaT keratinocytes secrete lysosomal cysteine proteinases during migration. Eur J Cell Biol 83(11-12):781-795
65. Buth H, Luigi Buttigieg P, Ostafe R, Rehders M, Dannenmann SR, Schaschke N, Stark HJ, Boukamp P, Brix K (2007) Cathepsin B is essential for regeneration of scratch-wounded normal human epidermal keratinocytes. Eur J Cell Biol 86(11-12):747-761
66. Buttle DJ (2007) Factors controlling matrix turnover in health and disease. Biochem Soc Trans 35 (Pt 4):643-646
67. Carlson EE, Cravatt BF (2007) Chemoselective probes for metabolite enrichment and profiling. Nat Methods 4(5):429-435
68. Caughey GH (2007) Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 217:141-154
69. Cauwe B, Opdenakker G (2010) Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit Rev Biochem Mol Biol 45(5):351-423
70. Cavallo-Medved D, Sloane BF (2003) Cell-surface cathepsin B: understanding its functional significance. Curr Top Dev Biol 54:313-341
71. Cawston TE, Young DA (2010) Proteinases involved in matrix turnover during cartilage and bone breakdown. Cell Tissue Res 339(1):221-235
72. Ceru S, Konjar S, Maher K, Repnik U, Krizaj I, Bencina M, Renko M, Nepveu A, Zerovnik E, Turk B, Kopitar-Jerala N (2010) Stefin B interacts with histones and cathepsin L in the nucleus. J Biol Chem 285(13):10078-10086
73. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253(1-2):269-285
74. Chambers RC, Laurent GJ (2002) Coagulation cascade proteases and tissue fibrosis. Biochem Soc Trans 30(2):194-200
75. Chapman HA (2004) Cathepsins as transcriptional activators?. Dev Cell 6(5):610-611
76. Chapman HA Jr, Munger JS, Shi GP (1994) The role of thiol proteases in tissue injury and remodeling. Am J Respir Crit Care Med 150(6 Pt 2):S155-S159
77. Chapman HA, Riese RJ, Shi GP (1997) Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59:63-88
78. Chen WT (1996) Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 49(1-3):59-71
79. Chen Y, Klionsky DJ (2011) The regulation of autophagy-unanswered questions. J Cell Sci 124 (Pt 2):161-170
80. Choi SY, Bertram S, Glowacka I, Park YW, Pohlmann S (2009) Type II transmembrane serine proteases in cancer and viral infections. Trends Mol Med 15(7):303-312
81. Ciechanover A (2003) The ubiquitin proteolytic system and pathogenesis of human diseases: a novel platform for mechanism-based drug targeting. Biochem Soc Trans 31(2):474-481
82. Ciechanover A (2005) Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 6(1):79-87
83. Ciechanover A, Iwai K (2004) The ubiquitin system: from basic mechanisms to the patient bed. IUBMB Life 56(4):193-201
84. Clegg JS (1991) Metabolic organization and the ultrastructure of animal cells. Biochem Soc Trans 19(4):986-991
85. Cobbe N, Marshall KM, Gururaja Rao S, Chang CW, Di Cara F, Duca E, Vass S, Kassan A, Heck MM (2009) The conserved metalloprotease invadolysin localizes to the surface of lipid droplets. J Cell Sci 122(Pt 18):3414-3423
86. Collins GA, Tansey WP (2006) The proteasome: a utility tool for transcription?. Curr Opin Genet Dev 16(2):197-202
87. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422(6927):37-44
88. Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295(5564):2387-2392
89. Creemers JW, Khatib AM (2008) Knock-out mouse models of proprotein convertases: unique functions or redundancy?. Front Biosci 13:4960-4971
90. Dano K, Behrendt N, Hoyer-Hansen G, Johnsen M, Lund LR, Ploug M, Romer J (2005) Plasminogen activation and cancer. Thromb Haemost 93(4):676-681
91. Das R, Pluskota E, Plow EF (2010) Plasminogen and its receptors as regulators of cardiovascular inflammatory responses. Trends Cardiovasc Med 20(4):120-124
92. Dash C, Kulkarni A, Dunn B, Rao M (2003) Aspartic peptidase inhibitors: implications in drug development. Crit Rev Biochem Mol Biol 38(2):89-119
93. Dauth S, Arampatzidou M, Rehders M, Yu DMT, Tedelind S, Brix K (2011) Thyroid cathepsin K-roles in physiology and thyroid disease. Clin Rev Bone Miner Metab 9:94-106
94. Dauth S, Sirbulescu RF, Jordans S, Rehders M, Avena L, Oswald J, Lerchl A, Saftig P, Brix K (2011) Cathepsin K deficiency in mice induces structural and metabolic changes in the central nervous system that are associated with learning and memory deficits. BMC Neurosci 12(1):74
95. Dauth S, Schmidt MM, Rehders M, Dietz F, Kelm S, Dringen R, Brix K (2012) Characterization and metabolism of astroglia-rich primary cultures from cathepsin K-deficient mice. Biol Chem 393:959-970
96. Davies KJ (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83 (3-4):301-310
97. De Mot R, Nagy I, Walz J, Baumeister W (1999) Proteasomes and other self-compartmentalizing proteases in prokaryotes. Trends Microbiol 7(2):88-92
98. De Strooper B, Annaert W (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 113(Pt 11):1857-1870
99. Declercq W, Vanden Berghe T, Vandenabeele P (2009) RIP kinases at the crossroads of cell death and survival. Cell 138(2):229-232
100. Degli Esposti M (2008) Organelle intermixing and membrane scrambling in cell death. Methods Enzymol 442:421-438
101. Desmarais S, Masse F, Percival MD (2009) Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools. Biol Chem 390(9):941-948
102. Deveraux QL, Stennicke HR, Salvesen GS, Reed JC (1999) Endogenous inhibitors of caspases. J Clin Immunol 19(6):388-398
103. Di Cara F, Duca E, Dunbar DR, Cagney G, Heck MM (2013) Invadolysin, a conserved lipid droplet-Associated metalloprotease, is required for mitochondrial function in Drosophila. J Cell Sci, in press, doi:10.1242/jcs.133306
104. Dice JF (1987) Molecular determinants of protein half-lives in eukaryotic cells. FASEB J 1 (5):349-357
105. Dice JF (1990) Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 15(8):305-309
106. Dice JF (2007) Chaperone-mediated autophagy. Autophagy 3(4):295-299
107. Dice JF, Walker CD (1979) Protein degradation in metabolic and nutritional disorders. Ciba Found Symp 75:331-350
108. Dikic I, Schmidt MH (2010) Notch: implications of endogenous inhibitors for therapy. Bioessays 32(6):481-487
109. Dobson CM (2003) Protein folding and misfolding. Nature 426(6968):884-890
110. Docherty K, Steiner DF (1982) Post-Translational proteolysis in polypeptide hormone biosynthesis. Annu Rev Physiol 44:625-638
111. Doucet A, Butler GS, Rodriguez D, Prudova A, Overall CM (2008) Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-Translational modifications of the cancer proteome. Mol Cell Proteomics 7(10):1925-1951
112. Drag M, Salvesen GS (2010) Emerging principles in protease-based drug discovery. Nat Rev Drug Discov 9(9):690-701
113. Driscoll JJ, Dechowdhury R (2010) Therapeutically targeting the SUMOylation, ubiquitination and proteasome pathways as a novel anticancer strategy. Target Oncol 5(4):281-289
114. Dunn BM, Oda K, Kay J, Rao-Naik C, Lowther WT, Beyer BM, Scarborough PE, BukhtiyarovaM (1998) Comparison of the specificity of the aspartic proteinases towards internally consistent sets of oligopeptide substrates. Adv Exp Med Biol 436:133-138
115. Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424
116. Edwards DR, Handsley MM, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29(5):258-289
117. Ehrmann M, Clausen T (2004) Proteolysis as a regulatory mechanism. Annu Rev Genet 38:709-724
118. Ellis V (2003) Plasminogen activation at the cell surface. Curr Top Dev Biol 54:263-312
119. Farquhar MG, Palade GE (1981) The Golgi apparatus (complex)-(1954-1981)-from artifact to center stage. J Cell Biol 91(3 Pt 2):77s-103s
120. Farquhar MG, Palade GE (1998) The Golgi apparatus: 100 years of progress and controversy. Trends Cell Biol 8(1):2-10
121. Felberbaum-Corti M, Van Der Goot FG, Gruenberg J (2003) Sliding doors: clathrin-coated pits or caveolae?. Nat Cell Biol 5(5):382-384
122. Fineschi B, Miller J (1997) Endosomal proteases and antigen processing. Trends Biochem Sci 22 (10):377-382
123. Freeman M (2008) Rhomboid proteases and their biological functions. Annu Rev Genet 42:191-210
124. Fricker LD (1988) Carboxypeptidase E. Annu Rev Physiol 50:309-321
125. Friedl P, Wolf K (2003) Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem Soc Symp 70:277-285
126. Friedl P, Wolf K (2009) Proteolytic interstitial cell migration: a five-step process. Cancer Metastasis Rev 28(1-2):129-135
127. Friedrichs B, Tepel C, Reinheckel T, Deussing J, von Figura K, Herzog V, Peters C, Saftig P, Brix K (2003) Thyroid functions of mouse cathepsins B, K, and L. J Clin Invest 111(11):1733-1745
128. Frittoli E, Palamidessi A, Disanza A, Scita G (2011) Secretory and endo/exocytic trafficking in invadopodia formation: the MT1-MMP paradigm. Eur J Cell Biol 90(2-3):108-114
129. Fritz H, Schiessler H, Schleuning WD (1973) Proteinases and proteinase inhibitors in the fertilization process: new concepts of control?. Adv Biosci 10:271-286
130. Fu X, Parks WC, Heinecke JW (2008) Activation and silencing of matrix metalloproteinases. Semin Cell Dev Biol 19(1):2-13
131. Funkelstein L, Beinfeld M, Minokadeh A, Zadina J, Hook V (2010) Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides. Neuropeptides 44 (6):457-466
132. Gagescu R, Gruenberg J, Smythe E (2000) Membrane dynamics in endocytosis: structure-function relationship. Traffic 1(1):84-88
133. Gahmberg CG, Tolvanen M (1996) Why mammalian cell surface proteins are glycoproteins. Trends Biochem Sci 21(8):308-311
134. Galivan J, Ryan TJ, Chave K, Rhee M, Yao R, Yin D (2000) Glutamyl hydrolase. Pharmacological role and enzymatic characterization. Pharmacol Ther 85(3):207-215
135. Garten W, Hallenberger S, Ortmann D, Schafer W, Vey M, Angliker H, Shaw E, Klenk HD (1994) Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie 76(3-4):217-225
136. Gerasimenko JV, Gerasimenko OV, Petersen OH (2001) Membrane repair: Ca(2+)-elicited lysosomal exocytosis. Curr Biol 11(23):R971-R974
137. Gerlt JA, Babbitt PC (2001) Divergent evolution of enzymatic function: mechanistically diverse superfamilies and functionally distinct suprafamilies. Annu Rev Biochem 70:209-246
138. Gocheva V, Joyce JA (2007) Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6(1):60-64
139. Goldberg AL, Dice JF (1974) Intracellular protein degradation in mammalian and bacterial cells. Annu Rev Biochem 43:835-869
140. Gomez-Lazaro M, Rinn C, Aroso M, Amado F, SchraderM(2010) Proteomic analysis of zymogen granules. Expert Rev Proteomics 7(5):735-747
141. Gomis-Ruth FX (2008) Structure and mechanism of metallocarboxypeptidases. Crit Rev Biochem Mol Biol 43(5):319-345
142. Gomis-Ruth FX, Botelho TO, Bode W (2012) A standard orientation for metallopeptidases. Biochim Biophys Acta 1824(1):157-163
143. Goulet B, Nepveu A (2004) Complete and limited proteolysis in cell cycle progression. Cell Cycle 3(8):986-989
144. Goulet B, Baruch A, Moon NS, Poirier M, Sansregret LL, Erickson A, Bogyo M, Nepveu A (2004) A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell 14(2):207-219
145. Goulet B, Sansregret L, Leduy L, Bogyo M, Weber E, Chauhan SS, Nepveu A (2007) Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation. Mol Cancer Res 5(9):899-907
146. Goulet B, Markovic Y, Leduy L, Nepveu A (2008) Proteolytic processing of cut homeobox 1 by neutrophil elastase in the MV4;11 myeloid leukemia cell line. Mol Cancer Res 6(4):644-653
147. Greenbaum D, Baruch A, Hayrapetian L, Darula Z, Burlingame A, Medzihradszky KF, Bogyo M (2002) Chemical approaches for functionally probing the proteome. Mol Cell Proteomics 1 (1):60-68
148. Groettrup M, Soza A, Kuckelkorn U, Kloetzel PM (1996) Peptide antigen production by the proteasome: complexity provides efficiency. Immunol Today 17(9):429-435
149. Groettrup M, Khan S, Schwarz K, Schmidtke G (2001) Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?. Biochimie 83(3-4):367-372
150. Groettrup M, van den Broek M, Schwarz K, Macagno A, Khan S, de Giuli R, Schmidtke G (2001) Structural plasticity of the proteasome and its function in antigen processing. Crit Rev Immunol 21(4):339-358
151. Groettrup M, Kirk CJ, Basler M (2010) Proteasomes in immune cells: more than peptide producers?. Nat Rev Immunol 10(1):73-78
152. Groll M, Clausen T (2003) Molecular shredders: how proteasomes fulfill their role. Curr Opin Struct Biol 13(6):665-673
153. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R (1997) Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386(6624):463-471
154. Gruenberg J (2001) The endocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol 2 (10):721-730
155. Gruenberg J, Howell KE (1989) Membrane traffic in endocytosis: insights from cell-free assays. Annu Rev Cell Biol 5:453-481
156. Gruenberg J, Maxfield FR (1995) Membrane transport in the endocytic pathway. Curr Opin Cell Biol 7(4):552-563
157. Gruenberg J, Stenmark H (2004) The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 5(4):317-323
158. Gu F, Gruenberg J (1999) Biogenesis of transport intermediates in the endocytic pathway. FEBS Lett 452(1-2):61-66
159. Gu F, Aniento F, Parton RG, Gruenberg J (1997) Functional dissection of COP-I subunits in the biogenesis of multivesicular endosomes. J Cell Biol 139(5):1183-1195
160. Gumy LF, Tan CL, Fawcett JW (2010) The role of local protein synthesis and degradation in axon regeneration. Exp Neurol 223(1):28-37
161. Ha Y (2007) Structural principles of intramembrane proteases. Curr Opin Struct Biol 17 (4):405-411
162. Hajjar KA, Acharya SS (2000) Annexin II and regulation of cell surface fibrinolysis. Ann NY Acad Sci 902:265-271
163. Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, Domschke W, Lippert H, Peters C, Deussing J (2000) Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 106(6):773-781
164. Hansen TH, Bouvier M (2009) MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol 9(7):503-513
165. Haugen MH, Johansen HT, Pettersen SJ, Solberg R, Brix K, Flatmark K, Maelandsmo GM (2013) Nuclear legumain activity in colorectal cancer. PLoS One 8(1):e52980
166. He B, Lu N, Zhou Z (2009) Cellular and nuclear degradation during apoptosis. Curr Opin Cell Biol 21(6):900-912
167. Heck MM (1997) Condensins, cohesins, and chromosome architecture: how to make and break a mitotic chromosome. Cell 91(1):5-8
168. Hendrickx AP, Budzik JM, Oh SY, Schneewind O (2011) Architects at the bacterial surface-sortases and the assembly of pili with isopeptide bonds. Nat Rev Microbiol 9(3):166-176
169. Henrich S, Lindberg I, Bode W, Than ME (2005) Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J Mol Biol 345 (2):211-227
170. Herget M, Tampe R (2007) Intracellular peptide transporters in human-compartmentalization of the 'peptidome'. Pflugers Arch 453(5):591-600
171. Hicke L, Dunn R (2003) Regulation of membrane protein transport by ubiquitin and ubiquitinbinding proteins. Annu Rev Cell Dev Biol 19:141-172
172. Hille A, Klumperman J, Geuze HJ, Peters C, Brodsky FM, von Figura K (1992) Lysosomal acid phosphatase is internalized via clathrin-coated pits. Eur J Cell Biol 59(1):106-115
173. Hiraiwa M (1999) Cathepsin A/protective protein: an unusual lysosomal multifunctional protein. Cell Mol Life Sci 56(11-12):894-907
174. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99(1):81-92
175. Hook V, Yasothornsrikul S, Greenbaum D, Medzihradszky KF, Troutner K, Toneff T, Bundey R, Logrinova A, Reinheckel T, Peters C, Bogyo M (2004) Cathepsin L and Arg/Lys aminopeptidase: a distinct prohormone processing pathway for the biosynthesis of peptide neurotransmitters and hormones. Biol Chem 385(6):473-480
176. Hook V, Schechter I, Demuth HU, Hook G (2008) Alternative pathways for production of betaamyloid peptides of Alzheimer's disease. Biol Chem 389(8):993-1006
177. Hooper NM (2002) Proteases: a primer. Essays Biochem 38:1-8
178. Hooper JD, Clements JA, Quigley JP, Antalis TM (2001) Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 276 (2):857-860
179. Howell KE, Devaney E, Gruenberg J (1989) Subcellular fractionation of tissue culture cells. Trends Biochem Sci 14(2):44-47
180. Hudson DF, Marshall KM, Earnshaw WC (2009) Condensin: architect of mitotic chromosomes. Chromosome Res 17(2):131-144
181. Ichihara A, Kaneshiro Y, Suzuki F (2006) Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension. Expert Opin Investig Drugs 15(10):1137-1139
182. Ishidoh K, Kominami E (2002) Processing and activation of lysosomal proteinases. Biol Chem 383(12):1827-1831
183. Itoh Y (2006) MT1-MMP: a key regulator of cell migration in tissue. IUBMB Life 58 (10):589-596
184. Ivanova S, Repnik U, Bojic L, Petelin A, Turk V, Turk B (2008) Lysosomes in apoptosis. Methods Enzymol 442:183-199
185. Izuhara K, Ohta S, Kanaji S, Shiraishi H, Arima K (2008) Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family. Cell Mol Life Sci 65(16):2541-2553
186. Jacques LB (1979) Heparin: an old drug with a new paradigm. Science 206(4418):528-533
187. Jedeszko C, Sameni M, Olive MB, Moin K, Sloane BF (2008) Visualizing protease activity in living cells: from two dimensions to four dimensions. Curr Protoc Cell Biol Chapter 4:Unit 4.20
188. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, Pei D (2001) Regulation of membrane-Type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U S A 98(24):13693-13698
189. Jordans S, Jenko-Kokalj S, Kuhl NM, Tedelind S, Sendt W, Bromme D, Turk D, Brix K (2009) Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions. BMC Biochem 10:23
190. Joyce JA, Hanahan D (2004) Multiple roles for cysteine cathepsins in cancer. Cell Cycle 3 (12):1516-1619
191. Kaiser CA, Chen EJ, Losko S (2002) Subcellular fractionation of secretory organelles. Methods Enzymol 351:325-338
192. Kaiserman D, Whisstock JC, Bird PI (2006) Mechanisms of serpin dysfunction in disease. Expert Rev Mol Med 8(31):1-19
193. Katzmann DJ, Odorizzi G, Emr SD (2002) Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol 3(12):893-905
194. Kennedy RD, D'Andrea AD (2005) The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev 19(24):2925-2940
195. Kenny AJ, Maroux S (1982) Topology of microvillar membrance hydrolases of kidney and intestine. Physiol Rev 62(1):91-128
196. Kersse K, Verspurten J, Berghe TV, Vandenabeele P (2011) The death-fold superfamily of homotypic interaction motifs. Trends Biochem Sci 36(10):541-552
197. Kessenbrock K, Dau T, Jenne DE (2011) Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. J Mol Med 89(1):23-28
198. Khan AR, James MN (1998) Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci 7(4):815-836
199. Kidd D, Liu Y, Cravatt BF (2001) Profiling serine hydrolase activities in complex proteomes. Biochemistry 40(13):4005-4015
200. Kim J, Hajjar KA (2002) Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci 7:d341-d348
201. Kirschke H, Wiederanders B (1994) Cathepsin S and related lysosomal endopeptidases. Methods Enzymol 244:500-511
202. Kirschke H, Barrett AJ, Rawlings ND (1995) Proteinases 1: lysosomal cysteine proteinases. Protein Profile 2(14):1581-1643
203. Klionsky DJ (2007) Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8(11):931-937
204. Kloetzel PM, Ossendorp F (2004) Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 16(1):76-81
205. Koohmaraie M (1992) The role of Ca(2+)-dependent proteases (calpains) in post mortem proteolysis and meat tenderness. Biochimie 74(3):239-245
206. Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10 (12):524-530
207. Korkmaz B, Moreau T, Gauthier F (2008) Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie 90 (2):227-242
208. Kornfeld S (1992) Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61:307-330
209. Koster A, Saftig P, Matzner U, von Figura K, Peters C, Pohlmann R (1993) Targeted disruption of the M(r) 46, 000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins. EMBO J 12(13):5219-5223
210. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P (2011) Emerging role of damage-Associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 32(4):157-164
211. Kveiborg M, Albrechtsen R, Couchman JR, Wewer UM (2008) Cellular roles of ADAM12 in health and disease. Int J Biochem Cell Biol 40(9):1685-1702
212. Kwak J, Workman JL, Lee D (2011) The proteasome and its regulatory roles in gene expression. Biochim Biophys Acta 1809(2):88-96
213. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P (2007) Caspases in cell survival, proliferation and differentiation. Cell Death Differ 14(1):44-55
214. Lamond AI, Earnshaw WC (1998) Structure and function in the nucleus. Science 280 (5363):547-553
215. Lecaille F, Weidauer E, Juliano MA, Bromme D, Lalmanach G (2003) Probing cathepsin K activity with a selective substrate spanning its active site. Biochem J 375(Pt 2):307-312
216. Lemansky P, Brix K, Herzog V (1998) Iodination of mature cathepsin D in thyrocytes as an indicator for its transport to the cell surface. Eur J Cell Biol 76(1):53-62
217. Lenarcic B, Bevec T (1998) Thyropins-new structurally related proteinase inhibitors. Biol Chem 379(2):105-111
218. Liaudet-Coopman E, Beaujouin M, Derocq D, Garcia M, Glondu-Lassis M, Laurent-Matha V, Prebois C, Rochefort H, Vignon F (2006) Cathepsin D: newly discovered functions of a longstanding aspartic protease in cancer and apoptosis. Cancer Lett 237(2):167-179
219. Lichtenthaler SF, Haass C, Steiner H (2011) Regulated intramembrane proteolysis-lessons from amyloid precursor protein processing. J Neurochem 117(5):779-796
220. Lin SX, Mallet WG, Huang AY, Maxfield FR (2004) Endocytosed cation-independent mannose 6-phosphate receptor traffics via the endocytic recycling compartment en route to the trans-Golgi network and a subpopulation of late endosomes. Mol Biol Cell 15(2):721-733
221. Linder S (2007) The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 17(3):107-117
222. Linke M, Herzog V, Brix K (2002) Trafficking of lysosomal cathepsin B-green fluorescent protein to the surface of thyroid epithelial cells involves the endosomal/lysosomal compartment. J Cell Sci 115(Pt 24):4877-4889
223. Linke M, Jordans S, Mach L, Herzog V, Brix K (2002) Thyroid stimulating hormone upregulates secretion of cathepsin B from thyroid epithelial cells. Biol Chem 383(5):773-784
224. Lipowsky R (1995) The morphology of lipid membranes. Curr Opin Struct Biol 5(4):531-540
225. List K, Bugge TH, Szabo R (2006) Matriptase: potent proteolysis on the cell surface. Mol Med 12 (1-3):1-7
226. Liu H, Lazarus SC, Caughey GH, Fahy JV (1999) Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro. Am J Physiol 276(1 Pt 1):L28-L34
227. Lopez-Otin C, Bond JS (2008) Proteases: multifunctional enzymes in life and disease. J Biol Chem 283(45):30433-30437
228. Lopez-Otin C, Matrisian LM (2007) Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7(10):800-808
229. Ludwig T, Munier-Lehmann H, Bauer U, Hollinshead M, Ovitt C, Lobel P, Hoflack B (1994) Differential sorting of lysosomal enzymes in mannose 6-phosphate receptor-deficient fibroblasts. EMBO J 13(15):3430-3437
230. Mach L (2002) Biosynthesis of lysosomal proteinases in health and disease. Biol Chem 383 (5):751-756
231. Mach L, Mort JS, Glossl J (1994) Maturation of human procathepsin B. Proenzyme activation and proteolytic processing of the precursor to the mature proteinase, in vitro, are primarily unimolecular processes. J Biol Chem 269(17):13030-13035
232. Mackie EJ, Pagel CN, Smith R, de Niese MR, Song SJ, Pike RN (2002) Protease-Activated receptors: a means of converting extracellular proteolysis into intracellular signals. IUBMB Life 53(6):277-281
233. Magdolen V, Arroyo de Prada N, Sperl S, Muehlenweg B, Luther T, Wilhelm OG, Magdolen U, Graeff H, Reuning U, Schmitt M (2000) Natural and synthetic inhibitors of the tumorassociated serine protease urokinase-Type plasminogen activator. Adv Exp Med Biol 477:331-341
234. Mai J, Waisman DM, Sloane BF (2000) Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta 1477(1-2):215-230
235. Manon-Jensen T, Itoh Y, Couchman JR (2010) Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J 277(19):3876-3889
236. Marfany G, Denuc A (2008) To ubiquitinate or to deubiquitinate: it all depends on the partners. Biochem Soc Trans 36(Pt 5):833-838
237. Matrisian LM (1999) Cancer biology: extracellular proteinases in malignancy. Curr Biol 9(20): R776-R778
238. Matteucci E, Giampietro O (2009) Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem 16(23):2943-2951
239. Mayer K. Schwartz S. Lentze M.J. Kalff J.C. Brix K. Extracellular Localization of Intestinal Cathepsins: Implications of Their Actions during Post-operative Ileus
240. Mayer K, Schwartz S, Lentze MJ, Kalff JC, Brix K (2006) Extracellular localization of intestinal cathepsins: implications of their actions during post-operative ileus. In: XLI congress of the European society for surgical research. Medimond International Proceedings, Rostock, Germany Mayer K, Iolyeva ME, Meyer-Grahle U, Brix K (2008) Intestine-specific expression of green fluorescent protein-Tagged cathepsin B: proof-of-principle experiments. Biol Chem 389 (8):1085-1096
241. Mayer K, Vreemann A, Qu H, Brix K (2009) Release of endo-lysosomal cathepsins B, D, and L from IEC6 cells in a cell culture model mimicking intestinal manipulation. Biol Chem 390 (5-6):471-480
242. McGrath ME (1999) The lysosomal cysteine proteases. Annu Rev Biophys Biomol Struct 28:181-204
243. McHugh B, Krause SA, Yu B, Deans AM, Heasman S, McLaughlin P, Heck MM (2004) Invadolysin: a novel, conserved metalloprotease links mitotic structural rearrangements with cell migration. J Cell Biol 167(4):673-686
244. McIntyre GF, Godbold GD, Erickson AH (1994) The pH-dependent membrane association of procathepsin L is mediated by a 9-residue sequence within the propeptide. J Biol Chem 269 (1):567-572
245. McNeil PL, Steinhardt RA (1997) Loss, restoration, and maintenance of plasma membrane integrity. J Cell Biol 137(1):1-4
246. Meister T, Niehues R, Hahn D, Domschke W, Sendler M, Lerch MM, Schnekenburger J (2010) Missorting of cathepsin B into the secretory compartment of CI-MPR/IGFII-deficient mice does not induce spontaneous trypsinogen activation but leads to enhanced trypsin activity during experimental pancreatitis-without affecting disease severit. J Physiol Pharmacol 61 (5):565-575
247. Mentlein R (2004) Cell-surface peptidases. Int Rev Cytol 235:165-213
248. Meusser B, Hirsch C, Jarosch E, Sommer T (2005) ERAD: the long road to destruction. Nat Cell Biol 7(8):766-772
249. Meyer-Hoffert U (2009) Neutrophil-derived serine proteases modulate innate immune responses. Front Biosci 14:3409-3418
250. Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451(7182):1069-1075
251. Mockaitis K, Estelle M (2008) Auxin receptors and plant development: a new signaling paradigm. Annu Rev Cell Dev Biol 24:55-80
252. Mohamed MM, Sloane BF (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6(10):764-775
253. Mondino A, Blasi F (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 25(8):450-455
254. Morita M, Kurochkin IV, Motojima K, Goto S, Takano T, Okamura S, Sato R, Yokota S, Imanaka T (2000) Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized proteins. Cell Struct Funct 25(5):309-315
255. Mort JS, Buttle DJ (1997) Cathepsin B. Int J Biochem Cell Biol 29(5):715-720
256. Mort JS, Recklies AD, Poole AR (1984) Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum 27 (5):509-515
257. Mott JD, Werb Z (2004) Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16(5):558-564
258. Mukherjee S, Ghosh RN, Maxfield FR (1997) Endocytosis. Physiol Rev 77(3):759-803
259. Munshi HG, Stack MS (2006) Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 25(1):45-56
260. Murphy G (2009) Regulation of the proteolytic disintegrin metalloproteinases, the 'Sheddases'. Semin Cell Dev Biol 20(2):138-145
261. Murphy G, Gavrilovic J (1999) Proteolysis and cell migration: creating a path?. Curr Opin Cell Biol 11(5):614-621
262. Murphy G, Nagase H (2011) Localizing matrix metalloproteinase activities in the pericellular environment. FEBS J 278(1):2-15
263. Murphy JE, Padilla BE, Hasdemir B, Cottrell GS, Bunnett NW (2009) Endosomes: a legitimate platform for the signaling train. Proc Natl Acad Sci U S A 106(42):17615-17622
264. Nagase H, Suzuki K, Itoh Y, Kan CC, Gehring MR, Huang W, Brew K (1996) Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation. Adv Exp Med Biol 389:23-31
265. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, Villadangos JA, Ploegh H, Peters C, Rudensky AY (1998) Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280(5362):450-453
266. Nakanishi H (2003) Microglial functions and proteases. Mol Neurobiol 27(2):163-176
267. Nakayama K (1997) Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327(Pt 3):625-635
268. Nasmyth K, Peters JM, Uhlmann F (2000) Splitting the chromosome: cutting the ties that bind sister chromatids. Science 288(5470):1379-1385
269. Navarro A, Anand-Apte B, Parat MO (2004) A role for caveolae in cell migration. FASEB J 18 (15):1801-1811
270. Nichols BJ, Lippincott-Schwartz J (2001) Endocytosis without clathrin coats. Trends Cell Biol 11 (10):406-412
271. Nicotra G, Castino R, Follo C, Peracchio C, Valente G, Isidoro C (2010) The dilemma: does tissue expression of cathepsin D reflect tumor malignancy? the question: does the assay truly mirror cathepsin D mis-function in the tumor?. Cancer Biomark 7(1):47-64
272. Nixon RA, Cataldo AM (1993) The lysosomal system in neuronal cell death: a review. Ann NY Acad Sci 679:87-109
273. Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, Maquoi E, Cataldo D, Foidart JM (2004) Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol 57(6):577-584
274. Norman LP, Matters GL, Crisman JM, Bond JS (2003) Expression of meprins in health and disease. Curr Top Dev Biol 54:145-166
275. Novinec M, Kordis D, Turk V, Lenarcic B (2006) Diversity and evolution of the thyroglobulin type-1 domain superfamily. Mol Biol Evol 23(4):744-755
276. O'Brien P, O'Connor BF (2008) Seprase: an overview of an important matrix serine protease. Biochim Biophys Acta 1784(9):1130-1145
277. Olson TS, Dice JF (1989) Regulation of protein degradation rates in eukaryotes. Curr Opin Cell Biol 1(6):1194-1200
278. Ong PC, McGowan S, Pearce MC, Irving JA, Kan WT, Grigoryev SA, Turk B, Silverman GA, Brix K, Bottomley SP, Whisstock JC, Pike RN (2007) DNA accelerates the inhibition of human cathepsin V by serpins. J Biol Chem 282(51):36980-36986
279. Ovaere P, Lippens S, Vandenabeele P, Declercq W (2009) The emerging roles of serine protease cascades in the epidermis. Trends Biochem Sci 34(9):453-463
280. Overall CM, Blobel CP (2007) In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol 8(3):245-257
281. Owen CA (2008) Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization. Int J Biochem Cell Biol 40(6-7):1246-1272
282. Owen CA, Campbell EJ (1995) Neutrophil proteinases and matrix degradation the cell biology of pericellular proteolysis. Semin Cell Biol 6(6):367-376
283. Pagano M, Reboud-Ravaux M (2011) Cryptic activities of fibronectin fragments, particularly cryptic proteases. Front Biosci 16:698-706
284. Palade GE (1964) The organization of living matter. Proc Natl Acad Sci U S A 52:613-634
285. Palade GE (1966) Structure and function at the cellular level. JAMA 198(8):815-825
286. Palade G (1975) Intracellular aspects of the process of protein synthesis. Science 189 (4200):347-358
287. Pappot H, Gardsvoll H, Romer J, Pedersen AN, Grondahl-Hansen J, Pyke C, Brunner N (1995) Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. Biol Chem Hoppe Seyler 376(5):259-267
288. Parkin ET, Turner AJ, Hooper NM (2004) Secretase-mediated cell surface shedding of the angiotensin-converting enzyme. Protein Pept Lett 11(5):423-432
289. Paulick MG, Bogyo M (2008) Application of activity-based probes to the study of enzymes involved in cancer progression. Curr Opin Genet Dev 18(1):97-106
290. Pelkmans L, Helenius A (2002) Endocytosis via caveolae. Traffic 3(5):311-320
291. Pellman D, Christman MF (2001) Separase anxiety: dissolving the sister bond and more. Nat Cell Biol 3(9):E207-E209
292. Peters C, von Figura K (1994) Biogenesis of lysosomal membranes. FEBS Lett 346(1):108-114
293. Peters C, Braun M, Weber B, Wendland M, Schmidt B, Pohlmann R, Waheed A, von Figura K (1990) Targeting of a lysosomal membrane protein: a tyrosine-containing endocytosis signal in the cytoplasmic tail of lysosomal acid phosphatase is necessary and sufficient for targeting to lysosomes. EMBO J 9(11):3497-3506
294. Pham CT (2006) Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6(7):541-550
295. Pham CT (2008) Neutrophil serine proteases fine-Tune the inflammatory response. Int J Biochem Cell Biol 40(6-7):1317-1333
296. Pickart CM (1997) Targeting of substrates to the 26S proteasome. FASEB J 11(13):1055-1066
297. Pickart CM (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70:503-533
298. Pickart CM, Eddins MJ (2004) Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 1695(1-3):55-72
299. Pickart CM, Fushman D (2004) Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol 8(6):610-616
300. Pillay CS, Elliott E, Dennison C (2002) Endolysosomal proteolysis and its regulation. Biochem J 363(Pt 3):417-429
301. Piper RC, Katzmann DJ (2007) Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 23:519-547
302. Platta HW, Erdmann R (2007) Peroxisomal dynamics. Trends Cell Biol 17(10):474-484
303. Podgorski I (2009) Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?. Future Med Chem 1(1):21-34
304. Pohlmann R, Boeker MW, von Figura K (1995) The two mannose 6-phosphate receptors transport distinct complements of lysosomal proteins. J Biol Chem 270(45):27311-27318
305. Pop C, Salvesen GS (2009) Human caspases: activation, specificity, and regulation. J Biol Chem 284(33):21777-21781
306. Potempa J, Sroka A, Imamura T, Travis J (2003) Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr Protein Pept Sci 4(6):397-407
307. Predescu SA, Predescu DN, Palade GE (2001) Endothelial transcytotic machinery involves supramolecular protein-lipid complexes. Mol Biol Cell 12(4):1019-1033
308. Pungercar JR, Caglic D, Sajid M, Dolinar M, Vasiljeva O, Pozgan U, Turk D, Bogyo M, Turk V, Turk B (2009) Autocatalytic processing of procathepsin B is triggered by proenzyme activity. FEBS J 276(3):660-668
309. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377 (9773):1276-1287
310. Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, Lopez-Otin C (2009) Matriptase-2-(TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 94(6):840-849
311. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3(7):489-501
312. Rawlings ND (2010) Peptidase inhibitors in the MEROPS database. Biochimie 92(11):1463-1483
313. Rawlings ND, Tolle DP, Barrett AJ (2004) Evolutionary families of peptidase inhibitors. Biochem J 378(Pt 3):705-716
314. Rechsteiner M (1990) PEST sequences are signals for rapid intracellular proteolysis. Semin Cell Biol 1(6):433-440
315. Rechsteiner M, Hill CP (2005) Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol 15(1):27-33
316. Reed SI (2003) Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat Rev Mol Cell Biol 4(11):855-864
317. Reinheckel T, Grune T, Davies KJ (2000) The measurement of protein degradation in response to oxidative stress. Methods Mol Biol 99:49-60
318. Reinheckel T, Deussing J, Roth W, Peters C (2001) Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol Chem 382(5):735-741
319. Reiser J, Adair B, Reinheckel T (2010) Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 120(10):3421-3431
320. Reiss K, Saftig P (2009) The 'a disintegrin and metalloprotease' (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol 20(2):126-137
321. Reudelhuber TL, Brechler V, Jutras I, Mercure C, Methot D (1998) Proteolytic and non-proteolytic activation of prorenin. Adv Exp Med Biol 436:229-238
322. Reverter D, Sorimachi H, Bode W (2001) The structure of calcium-free human m-calpain: implications for calcium activation and function. Trends Cardiovasc Med 11(6):222-229
323. Reyes-Turcu FE, Ventii KH, Wilkinson KD (2009) Regulation and cellular roles of ubiquitinspecific deubiquitinating enzymes. Annu Rev Biochem 78:363-397
324. Riedl SJ, Salvesen GS (2007) The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8(5):405-413
325. Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5(11):897-907
326. Riese RJ, Chapman HA (2000) Cathepsins and compartmentalization in antigen presentation. Curr Opin Immunol 12(1):107-113
327. Rivett AJ (1998) Intracellular distribution of proteasomes. Curr Opin Immunol 10(1):110-114
328. Rivett AJ, Hearn AR (2004) Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins. Curr Protein Pept Sci 5 (3):153-161
329. Rochefort H, Garcia M, Glondu M, Laurent V, Liaudet E, Rey JM, Roger P (2000) Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin Chim Acta 291 (2):157-170
330. Rockwell NC, Thorner JW (2004) The kindest cuts of all: crystal structures of Kex2 and furin reveal secrets of precursor processing. Trends Biochem Sci 29(2):80-87
331. Romisch K (2005) Endoplasmic reticulum-Associated degradation. Annu Rev Cell Dev Biol 21:435-456
332. Rosenberg GA (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8(2):205-216
333. Rosenblum JS, Kozarich JW (2003) Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr Opin Chem Biol 7(4):496-504
334. Rothman JE, Wieland FT (1996) Protein sorting by transport vesicles. Science 272(5259):227-234
335. Ruchaud S, Carmena M, Earnshaw WC (2007) Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 8(10):798-812
336. Sachse M, Urbe S, Oorschot V, Strous GJ, Klumperman J (2002) Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward lysosomes. Mol Biol Cell 13 (4):1313-1328
337. Saftig P, Reiss K (2011) The 'A Disintegrin And Metalloproteases' ADAM10 and ADAM17: novel drug targets with therapeutic potential?. Eur J Cell Biol 90(6-7):527-535
338. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-Kdeficient mice. Proc Natl Acad Sci U S A 95(23):13453-13458
339. Salvesen GS (2002) Caspases and apoptosis. Essays Biochem 38:9-19
340. Salvesen GS, Dixit VM (1997) Caspases: intracellular signaling by proteolysis. Cell 91 (4):443-446
341. Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3(6):401-410
342. Sameni M, Cavallo-Medved D, Dosescu J, Jedeszko C, Moin K, Mullins SR, Olive MB, Rudy D, Sloane BF (2009) Imaging and quantifying the dynamics of tumor-Associated proteolysis. Clin Exp Metastasis 26(4):299-309
343. Sato K, Kawashima S (2001) Calpain function in the modulation of signal transduction molecules. Biol Chem 382(5):743-751
344. Sato H, Takino T (2010) Coordinate action of membrane-Type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion. Cancer Sci 101 (4):843-847
345. Scamuffa N, Calvo F, Chretien M, Seidah NG, Khatib AM (2006) Proprotein convertases: lessons from knockouts. FASEB J 20(12):1954-1963
346. Schaller A, Ryan CA (1996) Systemin-A polypeptide defense signal in plants. Bioessays 18 (1):27-33
347. Schaschke N, Assfalg-Machleidt I, Machleidt W, Moroder L (1998) Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors. FEBS Lett 421(1):80-82
348. Schechter I (2005) Mapping of the active site of proteases in the 1960s and rational design of inhibitors/drugs in the 1990s. Curr Protein Pept Sci 6(6):501-512
349. Schenk S, Quaranta V (2003) Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol 13(7):366-375
350. Schmid SL (1993) Toward a biochemical definition of the endosomal compartment. Studies using free flow electrophoresis. Subcell Biochem 19:1-28
351. Schwartz DC, Hochstrasser M (2003) A superfamily of protein tags: ubiquitin, SUMO and related modifiers. Trends Biochem Sci 28(6):321-328
352. Schweitzer K, Naumann M (2010) Control of NF-kappaB activation by the COP9 signalosome. Biochem Soc Trans 38(Pt 1):156-161
353. Scott CC, Gruenberg J (2011) Ion flux and the function of endosomes and lysosomes: pH is just the start: the flux of ions across endosomal membranes influences endosome function not only through regulation of the luminal pH. Bioessays 33(2):103-110
354. Scott CJ, Taggart CC (2010) Biologic protease inhibitors as novel therapeutic agents. Biochimie 92(11):1681-1688
355. Seglen PO, Berg TO, Blankson H, Fengsrud M, Holen I, Stromhaug PE (1996) Structural aspects of autophagy. Adv Exp Med Biol 389:103-111
356. Seidah NG (2011) What lies ahead for the proprotein convertases?. Ann NY Acad Sci 1220:149-161
357. Seidah NG, Chretien M (1999) Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 848(1-2):45-62
358. Seidah NG, Prat A (2002) Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem 38:79-94
359. Seidah NG, Day R, Marcinkiewicz M, Benjannet S, Chretien M (1991) Mammalian neural and endocrine pro-protein and pro-hormone convertases belonging to the subtilisin family of serine proteinases. Enzyme 45(5-6):271-284
360. Seiki M (2002) The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol 14(5):624-632
361. Selkoe DJ, Wolfe MS (2007) Presenilin: running with scissors in the membrane. Cell 131 (2):215-221
362. Shi Z, Stack MS (2007) Urinary-Type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity. Biochem J 407(2):153-159
363. Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PG, Irving JA, Lomas DA, Luke CJ, Moyer RW, Pemberton PA, Remold-O'Donnell E, Salvesen GS, Travis J, Whisstock JC (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 276(36):33293-33296
364. Simionescu N, Simionescu M, Palade GE (1972) Permeability of intestinal capillaries. Pathway followed by dextrans and glycogens. J Cell Biol 53(2):365-392
365. Singhvi A, Garriga G (2009) Asymmetric divisions, aggresomes and apoptosis. Trends Cell Biol 19(1):1-7
366. Sloane BF, Yan S, Podgorski I, Linebaugh BE, Cher ML, Mai J, Cavallo-Medved D, Sameni M, Dosescu J, Moin K (2005) Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Semin Cancer Biol 15(2):149-157
367. Sloane BF, Sameni M, Podgorski I, Cavallo-Medved D, Moin K (2006) Functional imaging of tumor proteolysis. Annu Rev Pharmacol Toxicol 46:301-315
368. Smirnova IV, Ho GJ, Fenton JW II, Festoff BW (1994) Extravascular proteolysis and the nervous system: serine protease/serpin balance. Semin Thromb Hemost 20(4):426-432
369. Smith HW, Marshall CJ (2010) Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 11 (1):23-36
370. Sohail A, Sun Q, Zhao H, Bernardo MM, Cho JA, Fridman R (2008) MT4-(MMP17) and MT6-MMP (MMP25), a unique set of membrane-Anchored matrix metalloproteinases: properties and expression in cancer. Cancer Metastasis Rev 27(2):289-302
371. Sol-Church K, Picerno GN, Stabley DL, Frenck J, Xing S, Bertenshaw GP, Mason RW (2002) Evolution of placentally expressed cathepsins. Biochem Biophys Res Commun 293(1):23-29
372. Song L, Rape M (2008) Reverse the curse-The role of deubiquitination in cell cycle control. Curr Opin Cell Biol 20(2):156-163
373. Song Z, Steller H (1999) Death by design: mechanism and control of apoptosis. Trends Cell Biol 9 (12):M49-M52
374. Sorimachi H, Ishiura S, Suzuki K (1997) Structure and physiological function of calpains. Biochem J 328(Pt 3):721-732
375. Sorimachi H, Hata S, Ono Y (2010) Expanding members and roles of the calpain superfamily and their genetically modified animals. Exp Anim 59(5):549-566
376. Sounni NE, Noel A (2005) Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87(3-4):329-342
377. Squier TC (2006) Redox modulation of cellular metabolism through targeted degradation of signaling proteins by the proteasome. Antioxid Redox Signal 8(1-2):217-228
378. Stadtmueller BM, Hill CP (2011) Proteasome activators. Mol Cell 41(1):8-19
379. Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200(4):448-464
380. Steiner DF (1969) Proinsulin and the biosynthesis of insulin. N Engl J Med 280(20):1106-1113
381. Steiner DF (1998) The proprotein convertases. Curr Opin Chem Biol 2(1):31-39
382. Steiner H, Haass C (2000) Intramembrane proteolysis by presenilins. Nat Rev Mol Cell Biol 1 (3):217-224
383. Steiner DF, Quinn PS, Chan SJ, Marsh J, Tager HS (1980) Processing mechanisms in the biosynthesis of proteins. Ann NY Acad Sci 343:1-16
384. Sterchi EE, Stocker W, Bond JS (2008) Meprins, membrane-bound and secreted astacin metalloproteinases. Mol Aspects Med 29(5):309-328
385. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516
386. Stetler-Stevenson WG (2008) The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. Cancer Metastasis Rev 27(1):57-66
387. Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG (2011) The calpain system and cancer. Nat Rev Cancer 11(5):364-374
388. Strongin AY (2010) Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim Biophys Acta 1803(1):133-141
389. Stubbs MT, Bode W (1994) Coagulation factors and their inhibitors. Curr Opin Struct Biol 4 (6):823-832
390. Sun Y, Kucej M, Fan HY, Yu H, Sun QY, Zou H (2009) Separase is recruited to mitotic chromosomes to dissolve sister chromatid cohesion in a DNA-dependent manner. Cell 137 (1):123-132
391. Szabo R, Bugge TH (2008) Type II transmembrane serine proteases in development and disease. Int J Biochem Cell Biol 40(6-7):1297-1316
392. Tai HC, Schuman EM (2008) Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci 9(11):826-838
393. Takahashi T, Tang J (1981) Cathepsin D from porcine and bovine spleen. Methods Enzymol 80 (Pt C):565-581
394. Tallant C, Marrero A, Gomis-Ruth FX (2010) Matrix metalloproteinases: fold and function of their catalytic domains. Biochim Biophys Acta 1803(1):20-28
395. Tanaka Y, Tanaka R, Kawabata T, Noguchi Y, Himeno M (2000) Lysosomal cysteine protease, cathepsin B, is targeted to lysosomes by the mannose 6-phosphate-independent pathway in rat hepatocytes: site-specific phosphorylation in oligosaccharides of the proregion. J Biochem 128 (1):39-48
396. Tatnell PJ, Fowler SD, Bur D, Lees WE, Kay J (1998) Cathepsin E the best laid plans of mice and men. Adv Exp Med Biol 436:147-152
397. Tedelind S, Poliakova K, Valeta A, Hunegnaw R, Yemanaberhan EL, Heldin NE, Kurebayashi J, Weber E, Kopitar-Jerala N, Turk B, Bogyo M, Brix K (2010) Nuclear cysteine cathepsin variants in thyroid carcinoma cells. Biol Chem 391(8):923-935
398. Tedelind S, Jordans S, Resemann H, Blum G, Bogyo M, Fuhrer D, Brix K (2011) Cathepsin B trafficking in thyroid carcinoma cells. Thyroid Res 4(Suppl 1):S2
399. Tepel C, Bromme D, Herzog V, Brix K (2000) Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J Cell Sci 113 (Pt 24):4487-4498
400. Thomas G (2002) Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3(10):753-766
401. Tooze J, Hollinshead M, Hensel G, Kern HF, Hoflack B (1991) Regulated secretion of mature cathepsin B from rat exocrine pancreatic cells. Eur J Cell Biol 56(2):187-200
402. Travis J (1988) Structure, function, and control of neutrophil proteinases. Am J Med 84(6A):37-42
403. Travis J, Fritz H (1991) Potential problems in designing elastase inhibitors for therapy. Am Rev Respir Dis 143(6):1412-1415
404. Travis J, Salvesen GS (1983) Human plasma proteinase inhibitors. Annu Rev Biochem 52:655-709
405. Trombetta ES, Mellman I (2005) Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23:975-1028
406. Tschopp J, Martinon F, Burns K (2003) NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4(2):95-104
407. Tsukuba T, Okamoto K, Yasuda Y, Morikawa W, Nakanishi H, Yamamoto K (2000) New functional aspects of cathepsin D and cathepsin E. Mol Cells 10(6):601-611
408. Turk V, Bode W (1991) The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 285 (2):213-219
409. Turk B, Turk V (2009) Lysosomes as 'suicide bags' in cell death: myth or reality?. J Biol Chem 284(33):21783-21787
410. Turk B, Turk V, Turk D (1997) Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 378(3-4):141-150
411. Turk B, Turk D, Turk V (2000) Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta 1477(1-2):98-111
412. Turk V, Turk B, Turk D (2001) Lysosomal cysteine proteases: facts and opportunities. EMBO J 20 (17):4629-4633
413. Turk D, Turk B, Turk V (2003) Papain-like lysosomal cysteine proteases and their inhibitors: drug discovery targets?. Biochem Soc Symp 70:15-30
414. Turner AJ, Nalivaeva NN (2007) New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection. Int Rev Neurobiol 82:113-135
415. Uddin MN, Nabi AH, Nakagawa T, Ichihara A, Inagami T, Suzuki F (2008) Non-proteolytic activation of prorenin: activation by (pro)renin receptor and its inhibition by a prorenin prosegment, 'decoy peptide'. Front Biosci 13:745-753
416. Uhlmann F (2003) Separase regulation during mitosis. Biochem Soc Symp 70:243-251
417. Urban S (2010) Taking the plunge: integrating structural, enzymatic and computational insights into a unified model for membrane-immersed rhomboid proteolysis. Biochem J 425 (3):501-512
418. Urban S, Freeman M (2002) Intramembrane proteolysis controls diverse signalling pathways throughout evolution. Curr Opin Genet Dev 12(5):512-518
419. Urban S, Lee JR, Freeman M (2001) Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases. Cell 107(2):173-182
420. Van den Eynde BJ, Morel S (2001) Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Curr Opin Immunol 13(2):147-153
421. van Goor H, Melenhorst WB, Turner AJ, Holgate ST (2009) Adamalysins in biology and disease. J Pathol 219(3):277-286
422. van Meer G, de Kroon AI (2011) Lipid map of the mammalian cell. J Cell Sci 124(Pt 1):5-8
423. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11(10):700-714
424. Vanlangenakker N, Vanden Berghe T, Krysko DV, Festjens N, Vandenabeele P (2008) Molecular mechanisms and pathophysiology of necrotic cell death. Curr Mol Med 8(3):207-220
425. Varki A (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3 (2):97-130
426. Varki A (1998) Factors controlling the glycosylation potential of the Golgi apparatus. Trends Cell Biol 8(1):34-40
427. Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B (2007) Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des 13(4):387-403
428. Victor BC, Sloane BF (2007) Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function. Biol Chem 388(11):1131-1140
429. Vierstra RD (2009) The ubiquitin-26S proteasome system at the nexus of plant biology. Nat Rev Mol Cell Biol 10(6):385-397
430. Villadangos JA, Bryant RA, Deussing J, Driessen C, Lennon-Dumenil AM, Riese RJ, Roth W, Saftig P, Shi GP, Chapman HA, Peters C, Ploegh HL (1999) Proteases involved in MHC class II antigen presentation. Immunol Rev 172:109-120
431. Vreemann A, Qu H, Mayer K, Andersen LB, Stefana MI, Wehner S, Lysson M, Farcas AM, Peters C, Reinheckel T, Kalff J, Brix K (2009) Cathepsin B release from rodent intestine mucosa due to mechanical injury results in extracellular matrix damage in early post-Traumatic phases. Biol Chem 390(5-6):481-492
432. Watts C (2012) The endosome-lysosome pathway and information generation in the immune system. Biochim Biophys Acta 1824(1):14-21
433. Watts C, Matthews SP, Mazzeo D, Manoury B, Moss CX (2005) Asparaginyl endopeptidase: case history of a class II MHC compartment protease. Immunol Rev 207:218-228
434. Weihofen A, Martoglio B (2003) Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides. Trends Cell Biol 13(2):71-78
435. Whisstock JC, Bottomley SP (2006) Molecular gymnastics: serpin structure, folding and misfolding. Curr Opin Struct Biol 16(6):761-768
436. Whisstock JC, Bottomley SP (2008) Structural biology: serpins' mystery solved. Nature 455 (7217):1189-1190
437. White JM (2003) ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15(5):598-606
438. Wiederanders B, Kaulmann G, Schilling K (2003) Functions of propeptide parts in cysteine proteases. Curr Protein Pept Sci 4(5):309-326
439. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL (1996) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84(5):769-779
440. Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL (1996) Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384(6608):432-438
441. Wojcik C, DeMartino GN (2003) Intracellular localization of proteasomes. Int J Biochem Cell Biol 35(5):579-589
442. Wolf DH, Hilt W (2004) The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta 1695(1-3):19-31
443. Wolfe MS, Kopan R (2004) Intramembrane proteolysis: theme and variations. Science 305 (5687):1119-1123
444. Woodward JK, Holen I, Coleman RE, Buttle DJ (2007) The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer. Bone 41 (6):912-927
445. Wyllie AH, Kerr JF, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306
446. Yamamoto K (1995) Cathepsin E and cathepsin D: biosynthesis, processing and subcellular location. Adv Exp Med Biol 362:223-229
447. Yanagida M (2009) Clearing the way for mitosis: is cohesin a target?. Nat Rev Mol Cell Biol 10 (7):489-496
448. Yao C (2010) Major surface protease of trypanosomatids: one size fits all?. Infect Immun 78 (1):22-31
449. Yu DM, Wang XM, McCaughan GW, Gorrell MD (2006) Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J 273(11):2447-2460
450. Yu DM, Yao TW, Chowdhury S, Nadvi NA, Osborne B, Church WB, McCaughan GW, Gorrell MD (2010) The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J 277 (5):1126-1144
451. Zaidi N, Hermann C, Herrmann T, Kalbacher H (2008) Emerging functional roles of cathepsin E. Biochem Biophys Res Commun 377(2):327-330
452. Zhao JH, Yang CT, Wu JW, Tsai WB, Lin HY, Fang HW, Ho Y, Liu HL (2008) RING domains functioning as E3 ligases reveal distinct structural features: a molecular dynamics simulation study. J Biomol Struct Dyn 26(1):65-74
453. Zhou A, Webb G, Zhu X, Steiner DF (1999) Proteolytic processing in the secretory pathway. J Biol Chem 274(30):20745-20748
454. Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, Stanley PL, Stein PE, Broughton Pipkin F, Read RJ (2010) A redox switch in angiotensinogen modulates angiotensin release. Nature 468 (7320):108-111
455. Zogg T, Brandstetter H (2011) Complex assemblies of factors IX and X regulate the initiation, maintenance, and shutdown of blood coagulation. Prog Mol Biol Transl Sci 99:51-103